Vital Signs - Health Information Technology Takes on a Deadly Menace: A Look at How Baptist Health Uses TheraDocs Clinical Surveillance System to Combat Hospital-Acquired Infections

 


This issue of Vital Signs, released on October 8, 2012, provides a strategic insight on the use of healthcare information technology in combatting hospital-acquired infections.

Additionally, a company spotlight is provided for Hospira. Hospira, Inc.(NYSE: HSP) is a large global supplier of injectable drugs and infusion technologies for hospitals, clinics, home healthcare providers, and long-term care facilities. Reimbursement and regulatory news from the FDA is also provided for week of September 10, 2012.

Regular Price: USD 1,500

Special Price USD 1,125

25% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,125

PAY BY INVOICE

Be the first to review this product

Table of Contents

Vital Signs - Health Information Technology Takes on a Deadly Menace: A Look at How Baptist Health Uses TheraDoc’s Clinical Surveillance System to Combat Hospital-Acquired InfectionsVital Signs: 8th October 2012This week's issue




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.